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Abstract
Background: Glaucoma is one of the leading causes of irreversible blindness in the world. The major risk factor is
elevated intraocular pressure (IOP) leading to progressive retinal ganglion cell (RGC) death from the optic nerve
(ON) to visual pathways in the brain. Glaucoma has been reported to share mechanisms with neurodegenerative
disorders. We therefore hypothesize that neuroinflammatory mechanisms in central visual pathways may contribute
to the spread of glaucoma disease. The aim of the present study was to analyze the neuroinflammation processes
that occur from the pathological retina to the superior colliculi (SCs) in a rat model of unilateral ocular hypertension
induced by episcleral vein cauterization (EVC).
Results: Six weeks after unilateral (right eye) EVC in male Long-Evans rats, we evaluated both the neurodegenerative
process and the neuroinflammatory state in visual pathway tissues. RGCs immunolabeled (Brn3a+) in ipsilateral whole
flat-mounted retina demonstrated peripheral RGC loss associated with tissue macrophage/microglia activation (CD68+).
Gene expression analysis of hypertensive and normotensive retinas revealed a significant increase of pro-inflammatory
genes such as CCL2, IL-1β, and Nox2 mRNA expression compared to naïve eyes. Importantly, we found an
upregulation of pro-inflammatory markers such as IL-1β and TNFα and astrocyte and tissue macrophage/
microglia activation in hypertensive and normotensive RGC projection sites in the SCs compared to a naïve
SC. To understand how neuroinflammation in the hypertensive retina is sufficient to damage both right and
left SCs and the normotensive retina, we used an inflammatory model consisting in an unilateral stereotaxic
injection of TNFα (25 ng/μl) in the right SC of naïve rats. Two weeks after TNFα injection, using an optomotor test, we
observed that rats had visual deficiency in both eyes. Furthermore, both SCs showed an upregulation of genes and
proteins for astrocytes, microglia, and pro-inflammatory cytokines, notably IL-1β. In addition, both retinas exhibited a
significant increase of inflammatory markers compared to a naïve retina.
Conclusions: All these data evidence the complex role played by the SCs in the propagation of neuroinflammatory
events induced by unilateral ocular hypertension and provide a new insight into the spread of neurodegenerative
diseases such as glaucoma.
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Background
Glaucoma is the second leading cause of irreversible
blindness and is projected to affect 80 million people
worldwide by 2020, including at least 7 million people
who will become bilaterally blind [1]. Glaucoma is a
chronic degenerative optic neuropathy in which intraoc-
ular pressure (IOP) is abnormally elevated, leading to
the progressive loss of retinal ganglion cells (RGCs) and
an alteration of their axons. Today, high IOP is the
major risk factor and the current treatment strategy fo-
cuses on its ability to reduce IOP by pharmacological
or surgical means [2]. However, other mechanisms than
IOP increase seem to be involved in the development
and progression of this degenerative disease. Indeed,
glaucoma progression can be observed in 15–25 % of
patients despite appropriate IOP control [3, 4], and
normal-tension glaucoma comprises a significant pro-
portion of glaucoma cases in which an elevated IOP
cannot explain neurodegeneration. In addition, abnormal
activation of autoimmunity has been observed, which
could induce the loss of RGCs in glaucoma patients
without elevated IOP [5]. Consequently, this disease may
progress through an IOP-independent mechanism and
may involve other factors. In this way, numerous data
indicate that inflammatory responses in the retina could
appear earlier than the IOP rise [6–9]. In DBA/2J mouse
glaucoma model, it has been reported that young mice
present microglial activation in their retina and optic
nerve in absence of an elevated IOP context [10, 11]. In
addition, it has been suggested that astrocytes and Müller
cells exhibit an activated phenotype with morphologic
changes in retina before the increase of IOP. However,
inflammatory events induced by glaucoma occur not only
in the retina and the optic nerve (ON). In the human
brain, it has been clearly observed that neurodegenerative
processes also affect all layers of the lateral geniculate
nucleus (LGN), which constitutes the major target of
RGCs (corresponding to up to 80–90 % of RGC fibers)
[12, 13]. In contrast to humans, in the rodent visual sys-
tem, after decussating, the majority of RGC axons (90 %)
project directly to the contralateral superior colliculus
(SC) [14–16]. Thus, in a rat model of acute intraocular
hypertension, a strong astrogliosis has been shown in the
SC contralateral to the hypertensive eye [17]. Moreover, it
has been recently demonstrated that a deregulation of
cytokine signaling in the SC can appear before the IOP
or axonal degeneration in the DBA/2J mouse glaucoma
model [18].
The normotensive eye could also be affected by these
inflammatory changes. It has been observed that micro-
glia and astrocyte reactivity is upregulated in the retina
contralateral to the hypertensive eye in mice [19, 20]. How-
ever, the pathophysiology of neuroinflammatory events,
responsible for contralateral eye alteration, remains to be
clarified. Nevertheless, some data have provided evidence
of RGC axon projection from one retina to the other via
the optic chiasm and called retino-retinal projection path-
way [21, 22]. However, this bypass pathway remains minor
and concerns only a marginal proportion of axons [23, 24].
The SC could be the major structure of communication
by which neuroinflammatory events could spread to
both eyes. In rodents, after the optic chiasma, each SC
receives RGC axonal projections from both retinas in a
proportion of around 85/15 % [14–16, 22, 23, 25].
The purpose of this study was to understand how neu-
roinflammatory processes could spread to the normoten-
sive eye in the unilateral ocular hypertension glaucoma
model. To respond to this question, we first analyzed
the neuroinflammatory consequences of unilateral ocular
hypertension in visual pathway tissues including retinas,
optic nerves, and SCs in both episcleral vein cauterization
(EVC) and contralateral tissues. Then to demonstrate the
role played by the SC in the propagation of neuroinflam-
matory events induced by glaucoma, we used a model of
unilateral injection of TNFα into the right SC.
Methods
Animal model
Fifty male 8-week-old Long-Evans rats (Janvier Labs)
weighing 250–300 g were used. Animals were kept in
pathogen-free conditions with food and water available
ad libitum and housed in a 12-h light/12-h dark cycle.
All experiments were conducted after evaluation and
approval by the Institutional Animal Care and Use
Committee, Comité d'éthique pour l’expérimentation
animale Charles Darwin (reference number: 03858.02),
in accordance with the guidelines from Directive 2010/63/
EU of the European Parliament on the protection of
animals used for scientific purposes. For sample size and
number of rats used in each experiment see Table 1.
Induction of ocular hypertension and IOP measurements
The surgical ocular hypertension (OHT) model was
induced in the right eye of each rat by cauterization
of three episcleral veins after conjunctival dissection
under general anesthesia (intraperitoneal injection of
ketamine (100 mg/kg, Virbac, Vauvert, France) and xyla-
zine (10 mg/kg, Bayer HealthCare, Whippany, USA) as
previously described [26, 27]. Briefly, the superotemporal,
superonasal, and inferotemporal episcleral veins were
located and cauterized using a standard disposable oph-
thalmic cautery. The left eyes were used as contralateral
controls, and eyes from naïve animals were used as naïve
controls. At baseline and after the surgery, the animals
were maintained for a 6-week period and monitored for
IOP once a week using a handheld tonometer (TonoLab,
Medtronics, Jacksonville, USA). In this study, IOP average
values were calculated from three initial values from eight
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rats for the three groups (hypertensive, normotensive,
and control eyes) at each time point. During IOP
measurements, all the animals were awake.
Stereotaxic CTB-Alexa 594 and TNFα injection
Fourteen male Long-Evans rats (7 weeks old) were deeply
anesthetized with ketamine (100 mg/kg) and xylazine
(10 mg/kg) and placed on a digital stereotaxic frame. A
small drop of ophthalmic gel was placed on both eyes to
prevent corneal dehydration throughout the procedure.
The scalp was removed, and the skull was exposed. A
small craniotomy (1 mm× 1 mm2) was drilled above the
SC in the right hemisphere (mediolateral, 1.6 mm; antero-
posterior; −6.72 mm; dorsoventral, −4.2 mm from the
bregma). Four microliters of sterile recombinant rat TNFα
(25 ng/μl) (Biorad Laboratories, Nazareth, Belgium) or
cholera toxin subunit B (1 μg/μl) Alexa 594 (Life Tech-
nologies, Paisley, UK) were unilaterally injected into the
SC (1.2 μl/min). After injection, the needle was left for
5 min and removed slowly. The skull skin was stitched
and to recover, rats were placed for 1 h at 30 °C. The tis-
sue was analyzed 2 weeks after TNFα injection and 5 days
after CTB injection.
Optomotor response
The optokinetic tracking threshold was measured, under
photopic conditions, by observing the optomotor re-
sponses of rats to rotating sinusoidal gratings (OptoMotry,
CerebralMechanics, Alberta, Canada). Rats reflexively re-
spond to rotating vertical gratings by moving their head in
the direction of the grating rotation [28]. The protocol
yields independent measures of right and left eye acuity
based on the unequal sensitivity of the two eyes to pattern
rotation: the right and left eyes are most sensitive to
counter-clockwise and clockwise rotations, respectively.
Once the rat became accustomed to the pedestal, the test
was initiated by presenting the rat with a sinusoidal
striped pattern that rotates either clockwise or counter-
clockwise and varied widths. The software randomly in-
creased spatial frequency of the grating until the animal
no longer responded. The process of changing the spatial
frequency of the test grating was repeated a few times
until the highest spatial frequency the rat could track was
identified, which defines the optokinetic tracking thresh-
old under the experimental conditions. Experiments were
conducted after TNFα administration by two observers




At the end of the experiment, rats from each group were
deeply anesthetized via a single IP injection of ketamine
(75 mg/kg) and xylazine (10 mg/kg) and fixed by a
50 ml intraaortic perfusion of 0.9 % NaCl solution then
400 ml of 4 % paraformaldehyde in 1× phosphate buffer
saline (PBS; pH 7.4). After fixation, the eyes were carefully
removed and post-fixed for 1 h, then rinsed in 1× PBS
solution. The optic nerves were cut right after the eye, and
then the brain was removed with optic nerves. The ONs
and brains were post-fixed for 24 h and only ONs were
cryoprotected for 24 h by immersion in a 1× PBS solution
containing 30 % sucrose at 4 °C. For the immunofluores-
cence experiments, we used optic nerve part the most
close to the eye on 3 ml of length. Then the ONs were
included in a 7.5 % gelatin, 10 % sucrose mix, and frozen
at −20 °C. Retinal tissues were dissected intact from the
globe and flat-mounted.
Dual immunofluorescence labeling in whole flat-mounted
retina
For primary antibody and secondary references and
dilutions see Table 2.
The retinas were incubated for 2 h in a blocking-
permeabilizing solution of 1× PBS containing 10 %
bovine serum albumin (BSA), Triton X-100 2 %, and
Tween20 0.5 %. The retinas were incubated for 4 days
at 4 °C with monoclonal mouse anti-Brn-3a (1/100, Merck
Millipore, Darmstadt, Germany), polyclonal goat anti-Iba1
(1/400, Abcam, Cambridge, UK), or monoclonal mouse
anti-CD68 (1/400, AbD Serotec, Oxford, UK), washed
with 1× PBS six times for 20 min and incubated with
donkey anti-mouse conjugated with Alexa Fluor 594 (Life
Technologies) as the secondary antibody. The nuclei were
stained with Dapi (1/2000) for 1 h, and the retinal sections
Table 1 Sample size and number of rats used in each experiment
Episcleral vein cauterization experiments RT-PCR n = 8–10 rats 2 20
Immunohistofluorescence n = 6–7 rats 4 28
Stereotaxic CTB-Alexa 594 injection experiments Histofluorescence n = 4 rats 1 4
Stereotaxic TNFα injection experiments RT-PCR n = 8–10 rats 2 20
Immunohistofluorescence n = 6 rats 2 12
Total number of rats 84
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were mounted with Fluoromount (Sigma–Aldrich, St.
Louis, MO).
Dual immunofluorescence labeling for retinas, ON and
brain sections
Free-floating brain sections (thickness, 30 μm) were cut
with a vibratome (Leica, VT1000S) and collected in 1×
PBS. The retina and ON sections (thickness, 10 μm)
were cut with a cryostat (Leica, CM3050S) and kept
at −20 °C. The sections were washed several times in
1× PBS, blocked and permeabilized with 4 % BSA,
4 % normal horse serum (NHS), and 0.3 % Triton X-100
in 1× PBS for 2 h.
Sections were subsequently incubated overnight at
4 °C in 1× PBS containing 2 % BSA, 2 % NHS, and
0.15 % Triton X-100 with the following primary anti-
bodies: polyclonal goat anti-Iba1 (1/400, Abcam), mono-
clonal mouse anti-GFAP (Glial fibrillary acidic protein)
(1/500, Sigma–Aldrich), monoclonal mouse anti-CD68
(1/200, Abd Serotec), polyclonal rabbit anti-CCL2 (1/500,
Torrey-Pines), polyclonal rabbit anti-c-fos (1/500, Santa
Cruz, CA), monoclonal mouse anti-NeuN (1/500, Merck
Millipore), and rabbit anti-p-p38 (1/200, Cell Signaling
Technology, Beverly, MA).
Secondary antibodies included donkey anti-mouse and
anti-goat antibodies conjugated with Alexa Fluor 488 and
594 (1/500, Life Technologies) and biotinylated horse
anti-rabbit antibodies (1/500, Vector Labs, Burlingame,
USA) followed by a streptavidin Alexa Fluor 488 and 594
conjugate (1/500, Life Technologies). Staining with Dapi
(1/2000), a nuclear marker was also used. Sections were
then washed, mounted on gelatin-coated glass slides, and
coverslipped with Fluoromount. Control sections were
processed in parallel in the absence of either primary or
secondary antibodies.
Immunolabeling
Free-floating sections were incubated with 3 % H2O2 for
20 min and then with blocking/permeabilizing buffer
(see previous section). Sections were incubated overnight
at 4 °C (in 1× PBS containing 2 % BSA, 2 % NHS and
0.15 % Triton X-100) with GFAP and Iba1 antibodies.
The sections were incubated with biotinylated goat anti-
mouse and horse anti-goat antibodies (1/500, Vector
Labs) for 1 h and the Vectastain ABC kit (1/250, Vector
Labs) for 1 h. The color reaction was developed for
3–5 min with DAB+ (Sigma–Aldrich). The sections
were washed in 0.05 Tris buffer, pH 7.6, dehydrated
in Safesolv (no toxic xylene substitute, VWR Q Path,
Leighton Buzzard, UK) and coverslipped with Eukitt
mounting media.
Data analysis
Images were captured with a DM6000 microscope (Leica,
Nanterre, France) and analyzed using MetaMorph soft-
ware (Molecular Devices, Sunnyvale, CA). For labeling
density analysis, image files were inverted and opened in
gray-scale. Subsequently, using the thresholding function
of Fiji [29] to discriminate objects of interest from the
surrounding background, the total surface occupied by
immunoreactive structures (i.e., total stained pixels) above
this set threshold was estimated within a standard area
(ROI manager). Images were taken at objective ×20 on a
Leica microscope. The resulting values were expressed in
Table 2 Primary and secondary antibody references and dilutions
Dilution Host Antibody type Supplier
Primary antibodies
Brn-3a 1/100 Mouse Monoclonal Merck Millipore
Iba1 1/400 Goat Polyclonal abcam
CD68 1/200 or 1/400 Mouse Monoclonal AbD Serotec
GFAP 1/500 Mouse Monoclonal Sigma–Aldrich
CCL2 1/500 Rabbit Polyclonal Torrey–Pines
c-fos 1/500 Rabbit Polyclonal Santa Cruz
NeuN 1/500 Mouse Monoclonal Merck Millipore
p-p38 1/200 Rabbit Polyclonal Cell Signaling Technology
Secondary antibodies
Anti-mouse 1/500 Donkey Alexa Fluor 594 Life Technologies
Anti-goat 1/500 Donkey Alexa Fluor 594 Life Technologies
Anti-mouse 1/500 Donkey Alexa Fluor 488 Life Technologies
Anti-rabbit 1/500 Horse Biotinylated Vector Labs
Anti-mouse 1/500 Goat Biotinylated Vector Labs
Anti-goat 1/500 Horse Biotinylated Vector Labs
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surface units corresponding to 306,804 μm2. The results
were expressed as the mean ± SEM of six to eight values
per structure and per animal.
Images for co-localization were taken with an Olympus
FV1000 laser-scanning confocal microscope (Olympus,
Philadelphia, USA) and acquisitions were obtained using
the Olympus Fluoview software version 4.1.
RGCs and activated tissue macrophage/microglia labeling
and counting
Eight microscopic images were captured using a ×20
objective in the peripheral retina and then peripheral,
middle, and central regions in whole flat-mounted retina
labeled with Brn-3a and CD68 (which plays a role in
phagocytic activities of tissue macrophages) antibodies,
respectively. Images were captured with a DM6000 micro-
scope (Leica), and automatic enumeration of RGC nuclei
was assessed in a blind manner with MetaMorph software
(MolecularDevices). Iba1- and CD68-positive cells were
counted with the Fiji cell-counter plugin (ImageJ software,
NIH, Bethesda, MD, USA) [30]. The Iba1- and CD68-
positive cells in the central retina were quantified around
the ON head. In order to analyze the density of neuronal
cell population (labeled with the NeuN marker) in SC of
EVC and control groups we used an automatic counting
cell software (Explora Nova Morpho Strider; 2D Analysis).
mRNA extraction, reverse transcription, and real-time
polymerase chain reaction (RT-PCR)
Tissue preparation
At the end of the experiment, rats from each group were
deeply anesthetized using a single IP injection of ketamine
(75 mg/kg) and xylazine (10 mg/kg) and flushed with an
intraaortic perfusion of 0.9 % NaCl. The eyes were care-
fully removed and dissected, and the retinas were frozen
in dry ice. The rat brains were detached from the cranial
box and directly frozen in carbonic ice. Then the brains
were put in stainless steel coronal brain matrix (Harvard
Apparatus), and 1-mm slices were taken and micro-
dissected. Regions of interest (superior colliculi) were
frozen in liquid nitrogen.
mRNA extraction, reverse transcription, and RT-PCR
Total RNA levels in retinal tissues and brain punches were
assessed using the NucleoSpin RNA II and NucleoSpin
RNA XS Purification kit, respectively (Macherey-Nagel,
Düren, Germany). RNA concentration was evaluated
from absorbance measurements with NanoDrop (ND-
1000 spectrophotometer, Wilmington, USA).
RT-PCR
First-strand cDNA synthesis (20 μl reaction) was performed
with a High-Capacity cDNA Reverse Transcription kit
(Applied Biosystems, Life Technologies). Concentrations of
each sample were adjusted to 5 ng/μl of cDNA. Real-
time PCR amplification of each sample was performed
in triplicate, on the 7300 Real-Time PCR system (Ap-
plied Biosystems, Life Technologies). TaqMan® Gene
Expression Assays (Applied Biosystems) were used for
target genes: GFAP (Rn01460868_m1), IL1β (Rn0058
0432_m1), CCL2 (Rn00580555_m1), Nox2 (Rn00576
710_m1), Nox4 (Rn00585380_m1), TNFα (Rn01525
859_g1), CD68 (Rn01495634_g1), and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) (Rn01775763_g1).
Specific mRNA levels were calculated after normalization
of the results for each sample with those for GADPH
mRNA. The data are presented as relative mRNA units
with respect to control values.
Statistical analysis
All values are expressed as means ± SEM.
IOP measurement was analyzed using two-way ANOVA
for repeated measures followed by the Bonferroni post
hoc test. RGC counting, RT-qPCR data, CD68-positive
cells, and c-fos counting were analyzed using one-way
ANOVA, followed by the Tukey or Kruskal–Wallis or
Dunnett multiple comparisons post hoc tests. ON and SC
immunostaining levels of GFAP and Iba1 were analyzed
using one-way ANOVA followed by the Bonferroni post
hoc test. Statistical analyses were performed at the signifi-
cance level of 0.05 with Prism 6 GraphPad software (San
Diego, USA).
Results
Ocular hypertension leads to RGC death in the cauterized
eye and also affects the contralateral eye
IOP was measured with a tonometer and followed once
a week for 40 days. Immediately after the surgery, the
cauterized animals showed elevated IOP, which was
stable between 30 and 40 mmHg. Naïve and normotensive
(NT) eyes showed sustained normal IOP at 20 mmHg
(Fig. 1a). Six weeks after cauterization, the animals were
sacrificed and whole flat-mounted retina immunolabeling
of RGCs was performed. All experiments were done at
this time point. The images represent peripheral areas of
naïve, NT, and hypertensive (HT) eye retinas (Fig. 1b).
First, we observed that RGC density differed between
naïve and HT eyes. Indeed, the HT group exhibited a
significant 22 % decrease (p = 0.0184) in RGC density in
peripheral retina compared to the naïve group (Fig. 1c).
Furthermore, we did not observe any loss of RGC in the
middle and central retina in HT eyes compared with naïve
eyes (data not show). Moreover, there was a trend to the
decrease in RGC density in the NT group. Indeed, we
found an 8 % non-significant decrease compared to the
naïve group. Ocular hypertension induced RGC degener-
ation in peripheral retina 6 weeks after cauterization.
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Ocular hypertension induces retinal inflammation and
tissue macrophage activation in HT and NT eyes
An earlier study showed that in an unilateral laser-
induced OHT, the NT eye is also altered [20]. We aimed
to explore and further detail this new data in our ex-
perimental model of OHT. In all experiments, we com-
pared the EVC and contralateral structures to the naïve
structures.
EVC resulted in astrocyte activation (GFAP, p = 0.0007
with respect to naïve rats), in tissue macrophage activation
(CD68, p = 0.0309 with respect to naïve rats) (Fig. 2a).
There were also higher levels of mRNA for several key
proinflammatory and oxidative stress factors: IL-1β (p <
0.0001), CCL2 (p = 0.0015), and Nox2 (p = 0.0023) in HT
eye (Fig. 2b). For some genes, we found an increase in
mRNA levels in the NT eye: GFAP (p = 0.0150) and IL-1
(p = 0.0132).
We found tissue macrophage activation in the HT eye
retina and a trend toward an increase in the NT eye
retina. To investigate this increase in mRNA levels in
CD68 due to tissue macrophage/microglia activation,
whole flat-mounted retina double immunohistofluores-
cence of Iba1 and CD68 was performed. Pictures repre-
sent peripheral areas of naïve, contralateral, and EVC
retinas (Fig. 2c). We observed a change of microglia
morphology in HT and NT eye retinas, showing that
microglia cells acquire a reactive profile with short or
even absent processes and large soma called ameboid.
Quantification of Iba1+CD68+ cells (tissue macrophages/
microglia) in peripheral retina showed a twofold increase
in contralateral eyes compared to naïve eyes and in HT
eyes compared to NT eyes (Fig. 2d). We observed the
same type of result in the middle retina but to a lesser
extent (Fig. 2e). In the naïve eyes, the basal level of tissue
macrophages/microglia appeared to be higher in the
central retina than in the peripheral and middle retina. A
significant increase was still found in the NT eyes com-
pared to naïve eyes (Fig. 2f).
We also found a significant increase in the CCL2
mRNA level and in the number of tissue macrophages
in HT eye retinas. Given that previous studies have
assumed that CCL2 is strongly implicated in monocyte
recruitment during inflammation [30], we further wished
to determine which cells were expressing CCL2 in the
present model.
Ocular hypertension induces greater CCL2 expression by
astrocytes in HT and NT eye retinas
We showed that OHT resulted in increased expression
of CCL2 in HT eye retinas compared to naïve and NT
eye retinas and in NT eye retinas compared to naïve
retinas.
To define in which type of cells CCL2 was expressed,
we double stained the retinas with CCL2 and the specific
marker of astrocyte and Müller cell GFAP. Confocal
images showed that CCL2 was widely co-localized with
these cells specifically in the RGC layer (Fig. 2g). More-
over, GFAP and CCL2 labeling revealed a significant
increase in HT eye retina compared to naïve retina.
These data suggest that CCL2 is probably released by
astrocytes and Müller cells in both basal and injury
conditions.










































































Fig. 1 Cauterization leads to an elevated IOP and RGCs death. a IOP monitoring of HT right eye, NT eye, and naïve eye over 40 days (n = 8 per
group). b Peripheral area of whole flat-mounted retina marked with a white cross matching the region of interest. Whole flat-mounted retina
immunolabeled with Brn3a antibody. Representative images of the peripheral area showing immunopositive staining of RGCs in a naïve eye,
NT eye, and HT eye. Scale bar = 100 μm. c Quantification of peripheral RGC density per retina using automated nuclei counting in a naïve (n = 7),
NT (n = 6), and HT eye (n = 6). Each density corresponds to an average of RGCs determined from eight peripheral images per retina. Data are
expressed as means ± SEM. Two-way ANOVA for repeated measures followed by Bonferroni post hoc test was used for IOP: ****p < 0.0001 naïve
and NT versus HT eyes. One-way ANOVA, followed by the Dunnett multiple comparisons test was used for RGC counting: *p < 0.05 naïve versus
HT eyes
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Fig. 2 (See legend on next page.)
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Retinal astrogliosis and microgliosis are transmitted along
the ON
Segments of the ONs were examined for GFAP and Iba1
expression by immunofluorescence (Fig. 3a). Quantita-
tive analysis of the surface area covered by GFAP stain-
ing within the ON revealed almost a twofold increase
in the HT eye group compared to the naïve eye group
(p = 0.0415) (Fig. 3b). Surprisingly, the extent of Iba1
immunoreactivity in the NT eye group was at the same
level as in the naïve eye group but showed a twofold
increase in the HT eye group (p = 0.0476) (Fig. 3c).
Neuroinflammation in central visual projection pathways
After decussating, ON fibers divide in two ways in the
rodent brain. The minor synaptic relay that concerns
only a small percentage of fibers is the LGN. The major
ON fiber relay in the rat brain is the SC. We found in
the SC a similar profile of inflammation than in the
retina (Fig. 4). EVC led to astrocyte and tissue macro-
phage activation (increase in GFAP and CD68 mRNA
levels [p = 0.0136 and p = 0.0018, respectively], with
respect to naïve rats) (Fig. 4a). There were higher
levels of mRNA for proinflammatory and oxidative
stress factors: IL-1β (p = 0.0115), TNFα (p = 0.0134)
(Fig. 4b), Nox2 (p = 0.0004), and Nox4 (p < 0.0001)
(Fig. 4c) in HT eye retinas. For some genes, we found
an increase in mRNA levels in the NT eye: TNFα (p =
0.0175), CD68 (p = 0.0291), Nox2 (p = 0.003), and Nox4
(p = 0.0105).
To confirm these results, we performed immunochem-
istry in SCs. On the images of rat brain sections, SCs are
circled in red (Fig. 5a). In naïve SCs, GFAP labeling was
very rare and focused around the blood vessels and
under the pia mater (Fig. 5b). In left SC, dense GFAP
labeling was observed, indicating astrocyte activation. In
left SCs, microglia seemed to have a wider soma than in
naïve SCs (Fig. 5b).
Ocular hypertension induces c-fos and phosphorylated/
activated p38 (p-p38) activation in SC
Naïve, right and left SC sections were analyzed with
immunofluorescence with c-fos and NeuN markers
(Fig. 6a), and the number of neurons exhibiting the
(See figure on previous page.)
Fig. 2 EVC induces retinal inflammation and microglial activation in both HT and NT eyes. a, b RT-qPCR analysis of the effect of cauterization on
GFAP, CD68, IL-1β, CCL2, and Nox2 mRNA levels in naïve, NT, and HT eye retinas. mRNA levels are presented as a fold change relative to naïve rats
after normalization with respect to the housekeeping gene (GAPDH). Each bar is the mean ± SEM. n = 8–10 animals/group. c Peripheral images
from whole flat-mounted retina double-immunolabeled with Iba1 and CD68 antibody in naïve, NT, and HT eyes. Arrows show colocalization
between markers. Scale bar = 100 μm. c–e Quantification of peripheral (d), middle (e), and central (f) mononuclear phagocyte (Iba1+CD68+ cells)
density per retina in the naïve (n = 6), NT (n = 7), and HT (n = 7) eye groups. The average mononuclear phagocyte density values were determined
from eight peripheral, middle, or central images per retina. g Confocal images of double-immunolabeling of CCL2 with GFAP, an astrocytic marker, in
naïve, NT, and HT eye retinas. Arrowheads in inset show colocalization between markers. Scale bar = 100 μm. Results are expressed in arbitrary units
and correspond to the means ± SEM. We performed a one-way ANOVA followed by the Kruskal–Wallis multiple comparisons post hoc test: *p < 0.05,









































































































Fig. 3 EVC induces astrogliosis and microgliosis in ON.
a Immunofluorescent labeling for GFAP and Iba1 in naïve, NT, and HT
eye ON. Scale bar = 100 μm. Quantification of GFAP (b) and Iba1 (c)
immunofluorescence levels in naïve (n = 6), NT (n = 7), and HT (n = 7)
eye ON. Results are expressed in arbitrary units and correspond to the
means ± SEM. We performed a one-way ANOVA followed by the
Dunnett multiple comparisons post hoc test: *p < 0.05
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neuronal activation c-fos marker was counted (Fig. 6b).
The quantitative analysis showed a twofold increase in the
right group compared to the naïve group (p = 0.0385) and
nearly a threefold increase in the left group compared to
the naïve group (p = 0.001). These data suggested that
retinal inflammation increased second-order neuron acti-
vation in right and left SCs compared to naïve SCs.
In the next series of experiments, we investigated the
activation of the p-p38 pathway in the SCs (Fig. 6c). In
naïve SCs, only a few cells were immune-positive for
p-p38. In contrast, in right and left SCs, p-p38 was
exclusively detected in microglia and the positive cell
distribution did not change between right and left
SCs. Quantification of p-p38-positive cells confirmed
that this activation only occurred in right and left
SCs (Fig. 6d) (p < 0.0001).
HT eye inflammation is mostly transmitted to the NT eye
via the SCs
We hypothesized that the SC (the first relay in the rat
visual system) is the structure by which inflammation
can be transmitted to the contralateral eye. To verify this
hypothesis, we injected the CTB Alexa 594 into the right
SC of naïve rats. First, to test the quality of injection, we
made a single injection of CTB in the right SC (Fig. 7b).
We did not find CTB in the left SC (Fig. 7a). Then the
injection was localized in the superficial layers of the SC
[31], with most of the CTB fluorescence (in red) located
in the superficial SC (Fig. 7b). Five days after injection in
the right SC, the CTB was found in the right optic tract
nerve fibers (Fig. 7c). In rats, the majority of fibers
originating from the left retina projects to the right SC.
Indeed, we found a large number of RGCs containing
the fluorescent tracer in the left retina (Fig. 7d), while
in the right retina less stained RGCs were detected
(Fig. 7e).
After validating the quality and depth of injection, we
further injected TNFα (25 ng/μl) into the right SC of
naïve rats. Figure 8a illustrates the rat visual pathway
and the injection site. We observed whether or not RGC
fibers decussate at the optic chiasma. We also assessed


































































Fig. 4 EVC induces an increase of inflammatory markers at mRNA levels in right and contralateral SC. RT-qPCR analysis for GFAP, CD68 (a), IL-1β,
TNFα (b), Nox2, and Nox4 (c) mRNA levels in naïve, right, and contralateral SCs. For each marker, mRNA levels are presented as a fold change
relative to naïve rats after normalization with respect to the housekeeping gene (GAPDH). Each bar is the mean ± SEM. n = 8–10 animals/group.
We performed a one-way ANOVA followed by the Dunnett multiple comparisons post hoc test for GFAP, IL-1β, Nox2, and Nox4 and the Kruskal–
Wallis test for TNF-α and CD68: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001






Fig. 5 EVC induces astrogliosis and microgliosis in right and contralateral SCs. a Representative image of rat brain section showing the SC (circled
in red). b GFAP and Iba1 staining in naïve, right (Ipsi), and contralateral SCs. Scale bar = 100 μm (GFAP) and 50 μm (Iba1)
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by studying their optomotor responses to rotating sinus-
oidal gratings 5, 7, 9, and 15 days after TNFα injection
into the SC (Fig. 8b). These data indicate that the visual
function of rats treated with TNFα was impaired from
7 days up to 15 days after injection (p = 0.0446 for the
left eye versus the naïve eye and p = 0.0211 for the right
eye versus the naïve eye at 7 days; p = 0.0032 for the left
eye versus the naïve eye and p = 0.0006 for the right eye
versus the naïve eye at 9 days; p = 0.0025 for the left eye
versus the naïve eye and p = 0.0146 for the right eye
versus the naïve eye at 15 days).
RT-qPCR analysis of pro-inflammatory genes confirmed
our previous results. We observed a significant increase in
GFAP mRNA for astrogliosis (Fig. 8c) (p < 0.0001) in
CD68 mRNA for tissue macrophage/microglia activation
(Fig. 8d) (p < 0.0001) and in IL-1β mRNA (Fig. 8e) (p <
0.0001) in the right SC compared to a naïve SC. Some
genes were increased in the left SC, such as GFAP
(p < 0.0001), CD68 (p = 0.0044), and IL-1β (p = 0.0090).
TNFα injection produced wide astrogliosis and tissue
macrophage/microglia activation (Fig. 8f) in both left and
right SCs. Quantification of the number of Iba1+CD68+
cells showed an increase in the number of tissue macro-
phages/microglia in the left and right superficial SCs
compared to a naïve SCs (Fig. 8g). We also observed an
activation of the p-p38 pathway in microglia in the left
and right SCs, while no p-p38-positive cells were seen
in naïve SCs (Fig. 8f ). Quantification of the number
of Iba1+p-p38+ cells confirmed these results (Fig. 8h).
To evidence damage in both eyes, we performed whole
flat-mounted retina double immunohistochemistry for
Iba1 and CD68. The images show areas of naïve, right and
left retinas (Fig. 9a). We observed morphological changes






















































































































Fig. 6 EVC induces inflammation, c-fos, and p-p38 pathway activation in right and contralateral SCs. a Immunofluorescence of c-fos and NeuN in
naïve, right, and contralateral SCs. b Quantification of c-fos+ cells in naïve (n = 6), right (n = 7), and contralateral (n = 7) in superficial SCs. c Double-
immunofluorescent labeling p-p38/Iba1 in naïve, right (Ipsi), and contralateral SCs. d Quantification of Iba1+p-p38+ cells in naïve (n = 6), right
(n = 6), and contralateral (n = 6) SCs. Scale bars = 200 μm. Results are expressed in arbitrary units and correspond to the means ± SEM. We performed a
one-way ANOVA followed by the Dunnett multiple comparisons test: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001
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to activated tissue macrophages. Quantification of
Iba1+CD68+ cells (tissue macrophage/microglia activation)
in retinas showed more than a twofold increase in right
and left eyes compared to naïve eyes (Fig. 9b). To support
these results, we performed RT-qPCR analysis in the left
and right retinas in TNFα-treated rats compared to naïve
rats. We observed a significant increase of GFAP (Fig. 9c)
(p < 0.0001 in the left retina and p = 0.0074 in the
right retina compared to a naïve retina), CD68
(Fig. 9d) (p < 0.0001 in the left retina and p < 0.0001
in the right retina compared to a naïve retina), and IL-1β
(Fig. 9e) (p = 0.0006 in the left retina and p = 0.0005 in the
right retina compared to a naïve retina) mRNA in both
retinas. Then we evaluated RGC density in the projecting
retina after TNFα microinjection into the right SC
(Fig. 9f). We observed that TNFα injected into the right
SC induces a loss of ≈20 % of RGC in both retinas as com-
pare to control (p < 0.001 in the left retina and p < 0.001 in
the right retina compared to a naïve retina).
Discussion
In this study, we used an experimental model of glaucoma
(induced by EVC), which is very close to the human form
of the disease. Numerous studies have characterized and
used this EVC model, which matches specific glaucoma
symptoms: IOP increase with a reduction of aqueous
humor outflow, progressive RGC degeneration, aqueous
humor TGF-β2 level increase, and trabecular cell death
[2, 3, 32]. The EVC model used in this study shares
several features with human primary open-angle glau-
coma, but it is known there is blood flow damage.
Indeed, following episcleral/vortex veins cauterization,
arterial blood is suddenly left with insufficient outflow
from the globe. This would rapidly produce significant
ocular venous congestion, which is consistent with an
immediate rise in IOP observed in this ocular hyperten-
sive model [33]. In this EVC glaucoma model, RGC
loss is progressive (22 % decrease in peripheral retina
6 weeks after cauterization). This peripheral RGC loss
has also been observed in different glaucoma models
with, however, a markedly different percentage of RGC
loss. One study reports an 11 % decrease of RGC density
12 weeks after intracameral microbead injection in
mice [34], while another group showed a 30 % decrease
4 months after an association of microbead injection
and laser photocoagulation of the trabeculum mesh-
work in mice [35]. Other groups have developed EVC
model but in other rat strains. Thus, one study reported
15 % of RGC loss in peripheral retina 8 weeks after
EVC. In another study, the authors found a decrease of
40 % in RGC density 26 weeks after EVC [36], whereas
two other groups observed, 7 weeks after EVC, 30 % of
RGC loss in peripheral retina [37] and in the whole of
the retina for the other [38], respectively.
In neurodegenerative disease, a neuronal degeneration
is almost always associated with inflammation. There-
fore, in glaucomatous human eyes, an activated pheno-
type of astrocytes, Müller cells and microglia cells are
found in retinal layers [39]. Indeed, the hallmarks of glial
and microglial activation such as cellular body hyper-
trophy and increased expression of glial intermediate fil-
aments (GFAP) and tissue macrophage/microglia marker
Right SC Right OT






Fig. 7 Unilateral CTB injection in the right SC labels RGCs in both retinas. a CTB Alexa 594 was stereotaxically injected into the right SC. No
staining was observed in the left SC. b CTB in the right SC follows the needle path. Scale bar = 400 μm. c Neuronal fibers containing the CTB
tracer in the right optic tract (OT). Scale bar = 100 μm. d Numerous RGCs labeled with CTB in the left retina. e Only a few RGCs are labeled by
CTB in the right retina. Scale bar = 200 μm
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Fig. 8 (See legend on next page.)
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such as CD68 are classically observed in glaucomatous
eyes in humans [40] as well as in experimental models
of OHT [11, 41, 42].
In this study, we demonstrated that the increase of the
number of activated tissue macrophages/microglia in the
HT eye retina is correlated with an increase in CCL2
mRNA. In addition, we observed that CCL2 chemokine
is expressed by astrocytes. It is well known that CCL2 is
strongly implicated in monocyte chemoattractivity from
blood circulation to the inflammatory site [30]. Activated
tissue macrophages could stem from either activation of
resident microglia or activation of infiltrating mono-
cytes. Tissue macrophage/microglia activation could be
responsible for the increase in pro-inflammatory cyto-
kines (TNFα and IL-1β) observed in retina [42]. This
result is corroborated with a recent study that clearly
demonstrated that pro-inflammatory mediators signal
the progression of pathological changes in visual pro-
jection in a DBA/2J glaucoma model prior to functional
transport loss and RGC death [18].
We hypothesized that loss of RGCs can lead to RGC
axon impairments and ON gliosis. In this way, we clearly
(See figure on previous page.)
Fig. 8 Unilateral TNFα injection induces visual defect, inflammation, and p-p38 pathway activation in both SCs. a Diagram showing the neuronal
visual pathway in rodent. TNFα (25 ng/μl) is injected into the right SC. b The optomotor set-up allowed the determination of the optokinetic
tracking threshold measurements (cycles per degree) for the left and right eyes, independently scored (clockwise and counterclockwise responses,
respectively) under photopic conditions. Right and left eye sensitivity for naïve (n = 5), left (n = 6), and right (n = 6) rats at 5, 7, 9, and 15 days after
TNFα injection. RT-qPCR analysis for GFAP (c), CD68 (d), and IL-1β (e) mRNA levels in naïve, left, and right SCs. For each marker, mRNA levels are
presented as a fold change relative to naïve rats after normalization with respect to the housekeeping gene (GAPDH). Each bar is the mean ± SEM.
n = 8–10 animals/group. Immunofluorescence of GFAP, Iba1/CD68, and Iba1/p-p38 (f) in naïve, left, and right SCs. Arrows show colocalization between
markers. Scale bar = 200 μm (GFAP) and 50 μm (Iba1/CD68 and Iba1/p-p38). Quantification of Iba1+CD68+ cells (g) and Iba1 + p-p38+ cells (h) in naïve
(n = 5), left (n = 6), and right (n = 6) SCs. Results are expressed in arbitrary units and correspond to the means ± SEM. Two-way ANOVA for repeated
measures followed by Bonferroni post hoc test was used for optomotor responses: *p < 0.05, **p < 0.01, and ***p < 0.001 naïve, right, and left eyes. We
performed a one-way ANOVA followed by the Dunnett multiple comparisons test: **p < 0.01, ***p < 0.001, and ****p < 0.0001 and the Kruskal–Wallis
test for IL-1β
Fig. 9 SC inflammation induces inflammation and RGC loss in both retinas. a Whole flat-mounted retina double-immunolabeled with Iba1 and
CD68 in naïve, right, and left eyes of TNFα-injected rats. Arrows show colocalization between markers. Scale bar = 100 μm. b Quantification of
Iba1 + CD68+ cells per retina in the naïve group (n = 6), right eye (n = 6), and left eye (n = 6) groups. RT-qPCR analysis for GFAP (c), CD68 (d), and
IL-1β (e) mRNA levels in naïve, left, and right retinas. For each marker, mRNA levels are presented as a fold change relative to naïve rats after
normalization with respect to the housekeeping gene (GAPDH). Each bar is the mean ± SEM. n = 8–10 animals/group. Results are expressed in
arbitrary units and correspond to the means ± SEM. f Quantitation of RGCs loss in the projecting retina after TNFα stereotaxic microinjection into
the right SC. The resulting values were expressed in surface units corresponding to 306,804 μm2. We performed a one-way ANOVA followed by
the Dunnett multiple comparisons test: **p < 0.01, ***p < 0.001, and ****p < 0.0001 and the Kruskal–Wallis test for GFAP, and IL-1β
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observed a strong radial astrogliosis and tissue macro-
phage activation in the ON of the HT eye. These results
are consistent with other studies that have examined
glaucomatous ON. In a diode laser burn model, strong
GFAP immunostaining was found associated with a de-
generation of ON fibers [43]. In a 12-month-old DBA/2J
model, the authors are found lower β-Tubulin labeling
than in the control mice [44]. This suggests an antero-
grade deficit transport that can lead to damage in SCs.
In our experimental model of glaucoma, the SC is also
injured. The left SCs showed astrogliosis, microglia
activation, and elevated pro-inflammatory cytokine ex-
pression. In a model of acute perfusion of the anter-
ior chamber of the right eye with saline solution, they
found an increase in the number of GFAP-positive
astrocytes throughout the superficial layers of the left
SC [17]. In a model of laser photocoagulation of the
perilimbal and episcleral veins, they found a signifi-
cant enlargement of the GFAP within the left SC and
also in the right SC [45].
Increasing evidence supports that the glaucomatous
tissue stress (apoptosis of RGCs) initiated by inflamma-
tion involves reactive oxidative species (ROS) [46, 47].
This study found an increase in an oxidative stress
marker (Nox2) in HT eye retina. The Nox2 enzyme is
implicated in ROS synthesis, particularly in super-
oxide ion production. This result is corroborated by
the demonstration that in another experimental model
in which glaucoma is induced by chronic injection of
hyaluronic acid in the eye’s anterior chamber, a de-
crease in superoxide dismutase and catalase activity
was observed in total retina after 1 month [48].
Moreover, we found that oxidative stress markers,
Nox2 and Nox4, were also significantly elevated in
SCs. It is already known that oxidative stress by ROS
overproduction may significantly contribute to neuro-
degeneration [49].
In the present study, we hypothesized that retinal
inflammation in the HT eye could be transmitted to the
NT eye via the SC (the main projection site of RGCs in
rodents). Indeed, RGC axons from one retina project to
both SCs with 10–15 % RGC fibers coming from the
right eye and 85–90 % from the contralateral eye
[14–16, 22, 23, 25]. In our unilateral glaucoma model,
we observed an activation of second-order neurons
and/or interneurons in both SCs. Indeed, there is a
significant increase in the number of c-fos-positive
cells in both SCs compared to naïve SCs. c-fos is a
marker that could identify activated neurons in histo-
logical preparations. c-fos is a proto-oncogene that is
expressed within neurons following voltage-gated
calcium entry into the cell [50]. Neuronal excitation
leads to a rapid and transient induction of c-fos. We
demonstrated that c-fos is activated in left and right
SC after unilateral OHT. We postulated that neuroin-
flammation and RGC death induce activation of the
second-order neurons in both SCs. The right SC
analysis revealed, in an original way, an injury charac-
terized by microglia activation and elevated pro-
inflammatory cytokine expression. We hypothesized that
the 10–15 % of RGC fibers from the HT eye induce
neuroinflammation in the right SC.
We also found activation of the p-p38 pathway in
microglia in both left and right SC. It is already
known that p-p38 immunostaining was found in glia
of human glaucomatous retina [39]. Moreover, p38
could be activated and phosphorylated by pro-
inflammatory cytokines such as TNFα and IL-1β [51].
This observation is particularly true in our model
because we found an increase in TNFα expression in
both left and right SC. p-p38 activation is also
involved in apoptotic signaling, especially in RGCs
[52]. The NT eye analysis of EVC rats also displayed
astrogliosis and tissue macrophage/microglia activa-
tion. A research group has already shown damage in
the NT eye but only in the retina of OHT animals
[19, 20]. We wished to identify how this inflammation
could be transmitted to the NT eye. In the present
experimental model of OHT, the results clearly show
that the widespread inflammation observed in the HT
eye spread to the NT eye. We hypothesized that the
SC is the major site of antero- and retrograde com-
munications between the eyes. To test this hypothesis,
we injected an inflammatory cytokine (TNFα) into
the right SC, which receives approximately 10–15 %
RGC fibers from the right eye and 85–90 % RGC
fibers from the left eye. Thus, we showed that after
unilateral injection of TNFα into the right SC, both
right and left SCs present astrogliosis and tissue
macrophage/microglia activation. In addition, a sig-
nificant increase in the number of activated tissue
macrophages in both left and right eyes was associ-
ated with inflammation. These results contribute new
information to the history of glaucoma development.
Inflammation in one eye could activate RGC fibers
and induce inflammation in both SCs, which in turn may
activate inflammation in the other eye by retrograde trans-
port by way of RGC fibers. To corroborate this hypothesis,
RGCs have been traced from the SC using a neuro-
tracerdye such as Fluorogold [53], which was preferen-
tially concentrated in the cell body of RGCs during the
next 3–4 days. Moreover, in a model of Parkinson disease,
a retrograde degeneration of dopaminergic neurons
was observed after 6-hydroxydopamine (6-OHDA)
injection in the striatum, which receives substantia
nigra dopaminergic neuronal fibers. Striatal fibers degen-
erate, followed by cellular bodies located in substantia
nigra [54].
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Conclusions
These results demonstrate that elevated IOP induces
neuroinflammation in the retina of the damaged eye
but not only at the RGC level. This inflammation is
strongly associated with RGC degeneration and leads
to stress signal transmission in both SCs by RGC
axons. We observed glial cell activation in both SCs
and it is well known that activated glial cells produce
a wide range of inflammatory molecules that could
alter neuronal functioning. Damaged neurons of SCs
will in turn induce neuroinflammation in the left
retina that contains RGCs cell bodies and whose RGC
fibers project in both the left and right SCs. All of
these data evidence the complex role of the SCs in
the propagation of neuroinflammatory events induced
by glaucoma and provide new insight onto the devel-
opment of neurodegenerative diseases such as glaucoma.
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